Adial Pharmaceuticals retires all outstanding debt

• Adial Pharmaceuticals (NASDAQ:ADIL) announces that the holder of the sole remaining, outstanding convertible note has fully converted the balance of the note into common shares of the Company.
• As previously reported, the convertible note had a face value of $325,000 and was convertible into 162,500 shares of common stock.
• Shares are down 9% premarket.